Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance Development Seminar, 2016-08-20

Release date:

2020-08-22

On August 20, a development seminar of the Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance was held at Bodaweiye Pharmaceutical Co., Ltd., hosted by the Jilin Province Modern Traditional Chinese Medicine and Biopharmaceutical Base Construction Office and organized by Bodaweiye Pharmaceutical Co., Ltd. The event aimed to deepen the alliance's initiatives, foster the healthy growth of Jilin's chemical pharmaceutical industry, and drive technological innovation within the sector. Attending the meeting were representatives from the Jilin Provincial Department of Science and Technology, the Liaoyuan Municipal Bureau of Science and Technology, and the Management Committee of Liaoyuan Economic Development Zone. Additionally present were key leaders from Bodaweiye Pharmaceutical Co., Ltd., the chairman of the alliance’s board of directors, Duan Chengjun; the company’s general manager, Xie Wenbo; as well as executives from other alliance member companies, including Xue Chuanxiao, Chairman of Shihuida Pharmaceutical Group Co., Ltd., and Zhang Jun, Chairman of Xidian Pharmaceutical Technology Development Co., Ltd. Also in attendance were nearly 30 participants, including Li Hao, Dean of the School of Pharmacy at Yanbian University, along with representatives from four leading universities and research institutions. During the seminar, Duan Chengjun, Chairman of Bodaweiye Pharmaceutical Co., Ltd., and other pharmaceutical company leaders delivered keynote speeches. Attendees then engaged in discussions centered on the alliance’s operational mechanisms, management models, and priority tasks. Topics included technical needs and collaborative projects among members related to chemical drug R&D, pilot-scale testing, and production, as well as strategies for joint applications by alliance members to the 2016 Jilin Provincial Science and Technology Development Plan projects. Participants also shared ideas aimed at further clarifying the alliance’s strengths, strengthening collaboration, and leveraging complementary advantages, ultimately outlining specific goals and responsibilities for the alliance’s future activities. The meeting concluded with the adoption of a rotating chairmanship system, designating Xue Chuanxiao, Chairman of Shihuida Pharmaceutical Group Co., Ltd., as the 2016 rotating chairperson. Additionally, a specialized Technical Expert Committee was established, with Su Li, Director of the Jilin Provincial Institute of Pharmaceutical Research, appointed as its chairperson. Finally, a permanent secretariat was set up, and Liu Daocheng, Secretary-General of the Jilin Provincial Pharmaceutical Industry Association, was appointed as the alliance’s executive secretary-general. This meeting marked a significant step forward in fully advancing the work of the Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance, ensuring that its operations move toward greater scientific rigor, regularity, and institutionalization. It also enhanced the proactive engagement and enthusiasm of alliance members, fostering a mutually beneficial, interconnected, and highly efficient operating framework. Ultimately, these developments signify that the Jilin Province Chemical Pharmaceutical Innovation Strategic Alliance has entered a new phase of growth and maturity.

Promote the in-depth development of the Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance, and foster the healthy growth of Jilin Province's chemical pharmaceutical industry. August 20, The Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance Development Symposium was held at Bodaweiyi, hosted by the Jilin Province Modern Chinese Medicine and Biopharmaceutical Base Construction Office and organized by Jilin Province Bodaweiyi Pharmaceutical Co., Ltd.

Officials from the Jilin Provincial Department of Science and Technology, the Liaoyuan Municipal Bureau of Science and Technology, and the Management Committee of the Liaoyuan Economic Development Zone; Duan Chengjun, Chairman of Bodaweiye Pharmaceutical Co., Ltd., the leading organization of the Jilin Provincial Strategic Alliance for Technological Innovation in the Chemical Pharmaceutical Industry; Xie Wenbo, General Manager of the company; Xue Chuanxiao, Chairman of Shi Huida Pharmaceutical Group Co., Ltd., a vice-chairman unit; Zhang Jun, Chairman of Xidian Pharmaceutical Technology Development Co., Ltd.; and others Leaders from 12 companies, along with nearly 30 representatives—including Li Hao, Dean of the School of Pharmacy at Yanbian University—and heads from four universities and research institutions, attended the meeting.

At the meeting, Duan Chengjun, Chairman of Bodaweiye Pharmaceutical Co., Ltd., and heads of various pharmaceutical companies delivered important speeches. Attendees discussed the chemical drug alliance's operational mechanisms, management models, and key tasks, as well as the technical needs and collaborative projects in areas such as chemical drug R&D, pilot-scale production, and manufacturing among different organizations. They also explored opportunities for alliance members to jointly apply for funding and projects. Discussions were held regarding the 2016 Jilin Province Science and Technology Development Plan project; ideas were proposed to further assess existing resources, strengthen collaboration, and leverage complementary strengths. The specific tasks and work priorities for the Chemical Drugs Alliance in the coming period were also determined.

The meeting approved the establishment of a rotating chairmanship system for the alliance and appointed Xue Chuangxiao, Chairman of Shihuida Pharmaceutical Group Co., Ltd., as the chairperson. 2016 Annual Alliance Chairperson; established the Alliance Technical Expert Committee, appointing Li Su, Director of Jilin Province Institute of Pharmaceutical Research, as its Chairperson; and set up the Alliance’s permanent secretariat, hiring Liu Daocheng, Secretary-General of the Provincial Pharmaceutical Industry Association, as the Alliance’s Executive Secretary-General.

This meeting further propelled the comprehensive launch of the Jilin Province Chemical Pharmaceutical Industry Technology Innovation Strategic Alliance, helping to steer the alliance’s work onto a path of scientific rigor, institutionalization, and standardization. It also enhanced the initiative and enthusiasm of alliance members, fostering a mutually beneficial, collaborative, interconnected, and highly efficient operational system—marking the entry of Jilin Province’s chemical pharmaceutical innovation strategic alliance into a new phase of development.